CAS 31384-90-4
:Hippuryl-Gly-Gly
Bz-Gly-Gly-Gly [Hippuryl-Glycyl-Glycine]
CAS:Bz-Gly-Gly-Gly is a prodrug that is metabolized by enzymatic hydrolysis to its active form, hippurylglycylglycine. The prodrug has been shown to have minimal toxicity in mice and humans, and it binds to the target enzyme of infectious diseases (e.g., HIV) with high affinity. Bz-Gly-Gly-Gly has been shown to be effective in vitro against human immunodeficiency virus type 1 (HIV1) and mouse tumor models, as well as in vivo against mouse leukemia cells. The drug has also been shown to be safe at physiological levels in mice.
Formel:C13H15N3O5Reinheit:Min. 95%Molekulargewicht:293.28 g/molHippuryl-Gly-Gly-OH
CAS:Hippuryl-Gly-Gly-OH is a small molecule that inhibits the growth of bacteria. It is an inhibitor of epidermal growth factor (EGF) that binds to EGF and blocks its ability to interact with cells. Hippuryl-Gly-Gly-OH also has anti-inflammatory properties and has been shown to be effective against inflammatory bowel disease in vitro. This drug also has been shown to inhibit the enzyme activities associated with inflammatory bowel disease, such as COX2 and iNOS, in human serum, as well as inhibiting the production of proinflammatory cytokines from human peripheral blood mononuclear cells.
Formel:C13H15N3O5Reinheit:Min. 95%Molekulargewicht:293.28 g/mol

